The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing, and the Role of the Ophthalmologist in Reducing Both Reply

被引:0
作者
Browning, David J.
机构
关键词
D O I
10.1016/j.ajo.2016.07.007
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:240 / 241
页数:2
相关论文
共 6 条
[1]   Impact of the Revised American Academy of Ophthalmology Guidelines Regarding Hydroxychloroquine Screening on Actual Practice [J].
Browning, David J. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 155 (03) :418-428
[2]  
Francès C, 2012, ARCH DERMATOL, V148, P479, DOI 10.1001/archdermatol.2011.2558
[3]   Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy [J].
Marmor, Michael F. ;
Kellner, Ulrich ;
Lai, Timothy Y. Y. ;
Lyons, Jonathan S. ;
Mieler, William F. .
OPHTHALMOLOGY, 2011, 118 (02) :415-422
[4]   ANIMAL TOXICITY AND PHARMACOKINETICS OF HYDROXYCHLOROQUINE SULFATE [J].
MCCHESNEY, EW .
AMERICAN JOURNAL OF MEDICINE, 1983, 75 (1A) :11-18
[5]   METABOLISM OF CHLOROQUINE-3-14C IN RHESUS MONKEY [J].
MCCHESNEY, EW ;
SHEKOSKY, JM ;
HERNANDEX, PH .
BIOCHEMICAL PHARMACOLOGY, 1967, 16 (12) :2444-+
[6]  
MCHESNEY EW, 1966, J PHARMACOL EXP THER, V151, P482